Synthetic Biology Market
Synthetic Biology Market Forecasts to 2030 - Global Analysis By Product (Oligonucleotide, Enzymes, Cloning Technologies Kits, Synthetic DNA, Chassis Organism, Synthetic cells, Xeno-Nucleic Acids, Synthetic Clones and Other Products), Technology (Site-Directed Mutagenesis, Nanotechnology, Gene Synthesis, Bioinformatics, Measurement and Modelling, Genome Engineering, Sequencing, NGS Technology, Bioprocessing, Cloning, PCR Technology, Microfluidics and Other Technologies), Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $15.5 BN |
|
Projected Year Value (2030) |
US $52.6 BN |
|
CAGR (2023 - 2030) |
19% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Synthetic Biology Market is accounted for $15.5 billion in 2023 and is expected to reach $52.6 billion by 2030 growing at a CAGR of 19% during the forecast period. Synthetic biology is an advanced field of biology that uses modern science to engineer organisms in order to improve the development of medical and health services. Its applications vary and include cellular signalling, vaccine development, and antibody production. The process includes specific metabolic pathways that are necessary for identifying novel therapeutic targets for the treatment of a variety of illnesses, including infectious, immunological, and cancerous diseases.
According to SynBioBeta data, startups within the synthetic biology sector raised 18.0 billion in 2021.
Market Dynamics:
Driver:
Rising applications of synthetic biotechnology
The funding for synthetic biology research and development has increased due to the growing threat posed by pathogens, pollution, and the climate change crisis. The adoption of synthetic biology has increased in several industries that aim to lower their carbon footprints in order to prevent further rises in global temperatures. This is due to the technology's ability to replicate the properties of essential chemicals and materials without causing negative environmental effects. Therefore, rising research and development in synthetic biology are widening the scope of its applications, which will drive the market.
Restraint:
Bio safety concerns
The intentional or unintentional release of synthetic organisms into the environment for scientific purposes or other purposes poses the main bio safety risk in synthetic biology. When synthetic microorganisms are put into the atmosphere, they can mutate or interact with existing species, resulting in crossbreeding and bio errors. These consequences may endanger the habitats of wild animals. Moreover, a serious threat to bio security is the emergence of viruses that are resistant to antibiotics. These limitations could hamper market expansion in the coming years.
Opportunity:
Expanding applications in healthcare
In drug discovery, synthetic biology accelerates the identification and development of therapeutic compounds by constructing custom biological circuits. This not only enhances the efficiency of drug development but also opens avenues for the creation of more effective and targeted pharmaceuticals. Additionally, synthetic biology plays a crucial role in biopharmaceutical production, enabling the engineering of microorganisms for the synthesis of therapeutic proteins and vaccines. These rising applications in healthcare propel market demand.
Threat:
Limited predictability
The behavior of synthetic organisms and engineered biological circuits often exhibits unpredictability, posing challenges for researchers and developers. The complex interplay of biological components can result in unintended consequences, such as the emergence of unexpected behaviours or the failure of synthetic systems to perform as intended. However, this lack of predictability hinders the efficient design and optimization of synthetic biological systems, leading to time-consuming and resource-intensive trial-and-error approaches. Therefore, limited predictability is a significant element hampering market growth.
Covid-19 Impact
The synthetic biology market saw a minor downturn in growth during the COVID-19 pandemic, at first because of a decrease in production, then lockdown and a labor shortage. However, the market eventually saw resurgence in growth because of the increased need for novel treatments, vaccines, and diagnostics for COVID-19 management. The development of medications and research on the COVID vaccine supported synthetic biology research.
The chassis organism segment is expected to be the largest during the forecast period
The chassis organism segment is estimated to hold the largest share. These chassis organisms provide the essential biological framework onto which genetic circuits and components can be integrated to create novel functionalities or modified biological processes. Bacteria like Escherichia coli and yeasts like Saccharomyces cerevisiae are frequently used chassis organisms. These organisms are selected for their well-understood genetic backgrounds, ease of manipulation, and established tools for genetic engineering. The field's core idea of chassis organisms promotes innovation and developments in synthetic biology.
The PCR technology segment is expected to have the highest CAGR during the forecast period
The PCR technology segment is anticipated to have lucrative growth during the forecast period. Polymerase Chain Reaction (PCR) has evolved as a crucial technology for detecting and analyzing specific gene sequences. For most PCR-based genomic research, real-time PCR tests are the preferred approach due to their exceptional sensitivity and specificity. This approach is commonly utilized in forensic analysis, molecular diagnostics, DNA cloning, and genomics.
Region with largest share:
North America commanded the largest market share during the extrapolated period. The majority of the world's businesses and academic institutions that use synthetic biology in their drug development processes are located in North America. Advances in computer power, artificial intelligence, and genome mapping in this region have prompted researchers to quickly embrace new methods and build upon pre-existing concepts to create new capacities. Additionally, the cooperation of thousands of researchers, scientists, academic institutions, government departments, private investors, and product engineers has advanced the market in this region with new discoveries.
Region with highest CAGR:
Asia Pacific is expected to witness profitable growth over the projection period. Increasing investments in the Asia-Pacific region, more funding and partnerships in the Chinese market, and more collaboration in the field of synthetic biology are some of the factors anticipated to propel market growth. Additionally, Asia is also well-positioned to play a significant role in the application of synthetic biology toward the development of novel therapeutics. Governments and private investors in Asia are becoming increasingly interested in synthetic biology research and technology translation, where the field holds enormous promise for fostering a sustainable bio-based economy.
Key players in the market
Some of the key players in the Synthetic Biology Market include Synbio Technologies, GenScript, Agilent Technologies, Inc., Eurofins Genomics GmbH, Thermo Fisher Scientific, Amyris, Merck KGaA, Codexis, Inc., Integrated DNA Technologies, Inc., Synthego, EnBiotix, Inc., Genomatica, Inc., New England Biolabs (UK) Ltd. and Scarab Genomics, LLC.
Key Developments:
In April 2022, Merck KGaA Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System. The acquisition of the MAST platform is another milestone to accelerate innovation in Merck’s Process Solutions business unit.
In February 2022, Thermo Fisher Scientific announced the launch of GeneMapper Software, a flexible genotyping software package that provides DNA sizing and quality allele calls for all Thermo Fisher Scientific electrophoresis-based genotyping.
Products Covered:
• Oligonucleotide
• Enzymes
• Cloning Technologies Kits
• Synthetic DNA
• Chassis Organism
• Synthetic cells
• Xeno-Nucleic Acids
• Synthetic Clones
• Other Products
Technologies Covered:
• Site-Directed Mutagenesis
• Nanotechnology
• Gene Synthesis
• Bioinformatics
• Measurement and Modelling
• Genome Engineering
• Sequencing
• NGS Technology
• Bio processing
• Cloning
• PCR Technology
• Microfluidics
• Other Technologies
Applications Covered:
• Medical
• Environmental Applications
• Industrial Applications
• Food and Agricultural Applications
• Other Applications
End Users Covered:
• Academics & Research Institutes
• Biotechnology & Pharmaceutical Industry
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Synthetic Biology Market, By Product
5.1 Introduction
5.2 Oligonucleotide
5.3 Enzymes
5.4 Cloning Technologies Kits
5.5 Synthetic DNA
5.6 Chassis Organism
5.7 Synthetic cells
5.8 Xeno-Nucleic Acids
5.9 Synthetic Clones
5.10 Other Products
6 Global Synthetic Biology Market, By Technology
6.1 Introduction
6.2 Site-Directed Mutagenesis
6.3 Nanotechnology
6.4 Gene Synthesis
6.5 Bioinformatics
6.6 Measurement and Modelling
6.7 Genome Engineering
6.8 Sequencing
6.9 NGS Technology
6.10 Bioprocessing
6.11 Cloning
6.12 PCR Technology
6.13 Microfluidics
6.14 Other Technologies
7 Global Synthetic Biology Market, By Application
7.1 Introduction
7.2 Medical
7.2.1 Drug Discovery and Therapeutics
7.2.2 Pharmaceuticals
7.2.3 Artificial Tissue and Tissue Regeneration
7.3 Environmental Applications
7.3.1 Biosensing
7.3.2 Bioremediation
7.4 Industrial Applications
7.4.1 Industrial Enzymes
7.4.2 Biofuel and Renewable Energy
7.4.3 Biomaterials and Green Chemicals
7.5 Food and Agricultural Applications
7.5.1 Flavors and Fragrances
7.6 Other Applications
8 Global Synthetic Biology Market, By End-user
8.1 Introduction
8.2 Academics & Research Institutes
8.3 Biotechnology & Pharmaceutical Industry
8.4 Other End Users
9 Global Synthetic Biology Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Synbio Technologies
11.2 GenScript
11.3 Agilent Technologies, Inc.
11.4 Eurofins Genomics GmbH
11.5 Thermo Fisher Scientific
11.6 Amyris
11.7 Merck KGaA
11.8 Codexis, Inc.
11.9 Integrated DNA Technologies, Inc.
11.10 Synthego
11.11 EnBiotix, Inc.
11.12 Genomatica, Inc.
11.13 New England Biolabs (UK) Ltd.
11.14 Scarab Genomics, LLC
List of Tables
1 Global Synthetic Biology Market Outlook, By Region (2021-2030) ($MN)
2 Global Synthetic Biology Market Outlook, By Product (2021-2030) ($MN)
3 Global Synthetic Biology Market Outlook, By Oligonucleotide (2021-2030) ($MN)
4 Global Synthetic Biology Market Outlook, By Enzymes (2021-2030) ($MN)
5 Global Synthetic Biology Market Outlook, By Cloning Technologies Kits (2021-2030) ($MN)
6 Global Synthetic Biology Market Outlook, By Synthetic DNA (2021-2030) ($MN)
7 Global Synthetic Biology Market Outlook, By Chassis Organism (2021-2030) ($MN)
8 Global Synthetic Biology Market Outlook, By Synthetic cells (2021-2030) ($MN)
9 Global Synthetic Biology Market Outlook, By Xeno-Nucleic Acids (2021-2030) ($MN)
10 Global Synthetic Biology Market Outlook, By Synthetic Clones (2021-2030) ($MN)
11 Global Synthetic Biology Market Outlook, By Other Products (2021-2030) ($MN)
12 Global Synthetic Biology Market Outlook, By Technology (2021-2030) ($MN)
13 Global Synthetic Biology Market Outlook, By Site-Directed Mutagenesis (2021-2030) ($MN)
14 Global Synthetic Biology Market Outlook, By Nanotechnology (2021-2030) ($MN)
15 Global Synthetic Biology Market Outlook, By Gene Synthesis (2021-2030) ($MN)
16 Global Synthetic Biology Market Outlook, By Bioinformatics (2021-2030) ($MN)
17 Global Synthetic Biology Market Outlook, By Measurement and Modelling (2021-2030) ($MN)
18 Global Synthetic Biology Market Outlook, By Genome Engineering (2021-2030) ($MN)
19 Global Synthetic Biology Market Outlook, By Sequencing (2021-2030) ($MN)
20 Global Synthetic Biology Market Outlook, By NGS Technology (2021-2030) ($MN)
21 Global Synthetic Biology Market Outlook, By Bioprocessing (2021-2030) ($MN)
22 Global Synthetic Biology Market Outlook, By Cloning (2021-2030) ($MN)
23 Global Synthetic Biology Market Outlook, By PCR Technology (2021-2030) ($MN)
24 Global Synthetic Biology Market Outlook, By Microfluidics (2021-2030) ($MN)
25 Global Synthetic Biology Market Outlook, By Other Technologies (2021-2030) ($MN)
26 Global Synthetic Biology Market Outlook, By Application (2021-2030) ($MN)
27 Global Synthetic Biology Market Outlook, By Medical (2021-2030) ($MN)
28 Global Synthetic Biology Market Outlook, By Drug Discovery and Therapeutics (2021-2030) ($MN)
29 Global Synthetic Biology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
30 Global Synthetic Biology Market Outlook, By Artificial Tissue and Tissue Regeneration (2021-2030) ($MN)
31 Global Synthetic Biology Market Outlook, By Environmental Applications (2021-2030) ($MN)
32 Global Synthetic Biology Market Outlook, By Biosensing (2021-2030) ($MN)
33 Global Synthetic Biology Market Outlook, By Bioremediation (2021-2030) ($MN)
34 Global Synthetic Biology Market Outlook, By Industrial Applications (2021-2030) ($MN)
35 Global Synthetic Biology Market Outlook, By Industrial Enzymes (2021-2030) ($MN)
36 Global Synthetic Biology Market Outlook, By Biofuel and Renewable Energy (2021-2030) ($MN)
37 Global Synthetic Biology Market Outlook, By Biomaterials and Green Chemicals (2021-2030) ($MN)
38 Global Synthetic Biology Market Outlook, By Food and Agricultural Applications (2021-2030) ($MN)
39 Global Synthetic Biology Market Outlook, By Flavors and Fragrances (2021-2030) ($MN)
40 Global Synthetic Biology Market Outlook, By Other Applications (2021-2030) ($MN)
41 Global Synthetic Biology Market Outlook, By End user (2021-2030) ($MN)
42 Global Synthetic Biology Market Outlook, By Academics & Research Institutes (2021-2030) ($MN)
43 Global Synthetic Biology Market Outlook, By Biotechnology & Pharmaceutical Industry (2021-2030) ($MN)
44 Global Synthetic Biology Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
